263 related articles for article (PubMed ID: 22652139)
1. Blepharospasm and hemifacial spasm: long-term treatment with botulinum toxin.
Gil Polo C; Rodríguez Sanz MF; Berrocal Izquierdo N; Castrillo Sanz A; Gutiérrez Ríos R; Zamora García MI; Mendoza Rodríguez A; Duarte García-Luis J
Neurologia; 2013 Apr; 28(3):131-6. PubMed ID: 22652139
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
Wu CJ; Shen JH; Chen Y; Lian YJ
Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
Thussu A; Barman CR; Prabhakar S
Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
[TBL] [Abstract][Full Text] [Related]
4. Hemifacial spasm: results of treatment with low dose botulinum toxin injection.
Suputtitada A; Phanthumchinda K; Locharernkul C; Suwanwela NC
J Med Assoc Thai; 2004 Oct; 87(10):1205-11. PubMed ID: 15560699
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
6. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
Badarny S; Susel Z; Honigman S
Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
[TBL] [Abstract][Full Text] [Related]
7. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
Bihari K
Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
[TBL] [Abstract][Full Text] [Related]
8. [Long-term treatment with botulinum toxin: dosage, treatment schedules and costs].
Schnider P; Birner P; Moraru E; Auff E
Wien Klin Wochenschr; 1999 Jan; 111(2):59-65. PubMed ID: 10081123
[TBL] [Abstract][Full Text] [Related]
9. [The effect of botulinum A toxin repeated injection in treating blepharospasm and hemifacial spasm].
Wang J; Zhang X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Apr; 20(7):292-4. PubMed ID: 16780139
[TBL] [Abstract][Full Text] [Related]
10. Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment.
Quagliato EM; Carelli EF; Viana MA
Clin Neuropharmacol; 2010; 33(1):27-31. PubMed ID: 20124784
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
Kongsengdao S; Kritalukkul S
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
Cillino S; Raimondi G; Guépratte N; Damiani S; Cillino M; Di Pace F; Casuccio A
Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
[TBL] [Abstract][Full Text] [Related]
13. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA
Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with quality of life in hemifacial spasm and blepharospasm during long-term treatment with botulinum toxin.
Setthawatcharawanich S; Sathirapanya P; Limapichat K; Phabphal K
Qual Life Res; 2011 Nov; 20(9):1519-23. PubMed ID: 21431990
[TBL] [Abstract][Full Text] [Related]
15. [Blepharospasm and hemifacial spasm treated with botulinum A toxin injection].
Wang J; Lin S; Zhang X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Oct; 33(5):291-3. PubMed ID: 11717871
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of botulinum a toxin for blepharospasm and hemifacial spasm.
Gill HS; Kraft SP
Can J Neurol Sci; 2010 Sep; 37(5):631-6. PubMed ID: 21059510
[TBL] [Abstract][Full Text] [Related]
17. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
Chang LB; Tsai CP; Liao KK; Kao KP; Yuan CL; Yen DJ; Lin KP
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705
[TBL] [Abstract][Full Text] [Related]
18. [Results of long term treatment of essential blepharospasm and facial hemispasm with botulinum toxin A].
Ziak P
Cesk Slov Oftalmol; 2004 Jan; 60(1):37-44. PubMed ID: 15011305
[TBL] [Abstract][Full Text] [Related]
19. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
[TBL] [Abstract][Full Text] [Related]
20. [Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review].
Schellini SA; Matai O; Igami TZ; Padovani CR; Padovani CP
Arq Bras Oftalmol; 2006; 69(1):23-6. PubMed ID: 16491229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]